<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Q321 Market Recap: US Surgical Matrices

12/6/21 2:00 PM

US Surgical Matrices Market Recap Q321Procedures using surgical matrices maintained their new normal, with broad strength in both hernia and breast matrices.

Procedures using surgical matrices maintained their new normal, though the resurgence of Delta variant across the northern tier of states may put a dent in the market following deferrals of procedures in various regions as the COVID-19 Delta variant caused more procedural headwinds.

Among the many topics covered in detail in our comprehensive Q321 US Surgical Matrices Market Recap* are:

  • Complete Q321 US Surgical Matrices Market Overview
  • SmartTRAK's Expert Analysis and Insights
  • All Market News including Revenues, Data, Charts and Shares
  • US Surgical Matrices Market Makes It Back To Pre-COVID-19 Levels
  • US Breast Matrices: Back In Business
  • US Hernia Repair Matrices Market: Solid Growth In Q321
  • Important Q321 Market Events

The US Surgical Matrices market gained steam in Q321, gaining +10.0% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie continued to lead the Surgical Matrices market, gaining +21.0% YoY. Becton Dickinson (BD) also grew well, gaining +7.1% YoY and ...

Read the entire Q321 US Surgical Matrices Market Recap, including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More


SmartTRAK 
has recently expanded it's coverage to include five new modules. Click to see details of all the exciting new additions to the SmartTRAK platform in 2021.
 

Topics: Orthobiologics

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Follow Us on Social Media

    Recent Articles